1WILEKES G K, KULLIMS D, LUGER T A, et al. IL-1 protects keratinocytes from TRAIL and CD - 95 - induced apoptosis but nit from UV radiation - induced apoptosis[J]. J Biol Chem, 1999, 274(41 ) :28916.
3JOGNSEN A C, HAUX J, STENINKJER B, et al. Regulation of APO-2 ligand/TRAIL expression in NK cells involvement in NK cell-mediated cytotoxicity[J]. Cytokine, 1999,11 (9) :664.
4GRIFITH T S, RAUCH C T, SMOLAK P J, et al. Funtional analtsis of TRAIL receptors using monoclonal antibodies[J]. J Immunol, 1999,162(5) :2597.
5GOKE R, GOKE A, GOKE B, et al. Regulation of TRAIL - induced apoptosis by transcription factors [ J ]. Cell Immunol, 2000,201 (2) : 77- 82.
6CHEN L, IJU X, ZHU Y, et al. Localization and variation of TRAIL and its receptors in human placenta during gestation [ J ]. Life Sci,2004,74(12) :1479 - 1486.
7PHILLIPS T A, NI J, HUNT J S, et al. Death - inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placental, cytotrophoblasts, placental macrophages and placental cell lines[J]. Placenta, 2001,22(8/9) :663 - 672.
8POPOVICI R M, KAO L C, GIUDICE L C, et al. Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology[ J ]. Endocrinology, .2000,141 (9) :3510 -3513.
9LONERGAN M, APONSO D, MARVIN K W, et al. Tumor necrosis factor - related apoptosis - inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm[J]. J Clin Endocrinol Metab, 2003,88(8) :3835 - 3844.
10TERESA A. P, JIAN NI, GUOHUA PAN,et al. TRAIL (Apo- 2L)and TRAIL receptors in human placentas: implications for immune privilege [J]. Immunol, 1999, 162: 6053- 6059.
二级参考文献75
1Bulla R, Bossi F, Radillo O, et al. Placenta trophoblast and endothelial cells as target of maternal immune response. Autoimmunity,2003, 36(1):11-18.
2Elizabeth A. Maternal tolerance is not critically dependent on interleukin-4. Immunology, 2001,103:382-389.
3Murphy KM, Ouyang W, Farrar JD,et al. Signaling and transcription in T helper development. Annu Rev Immunol, 2000,18:451-494.
4Herrler A, von-Rango U, Beier HM. Embryo-maternal signaling: how the embryo starts talking to its mother to accomplish implantation.Reprod Biomed Online, 2003, 6(2):244-256.
5Makrigiannakis A, zoumakisE,Kalantaridou S, et al. Corticotropinreleasing hormone(CRH) and immunotolerance of the fetus. Biochem Pharmacol, 2003,65(6):917-921.
6Heikkinen J, Mottonen M, Komi J, et al. Phenotypic characterization of human decidual macrophages. Clin Exp Immunol, 2003,131 (3):498-505.
7Fuzzi B, Rizzo R, Criscuoli L, et al. HLA-G expression in early embryos is a fundamental preequisite for the obtainment of pregnancy.Eur J Immunol, 2002,32 (2): 311-315.
8Kauma S, Huff T, Hayes N, et al. Placental fas ligand eopression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metab,1999, 84:2188-2194.
9Gruslin A, Qiu Q, Tsang BK. X-linked inhibitor of apoptosis protein expression and the regulation of apoptosis during human placental development. Biol Relarod, 2001, 64(4): 1264-1272.
10Balkundi DR, Hanna N, Hileb MI et al. Labor-associated changes in Fas ligand expression and function in human placenta. Pediatr Res,2000, 47(3):301-308.
